Chika Uotani
Chika Uotani publishes mostly in Hematology, Pulmonary and Respiratory Medicine and Cancer Research, on topics such as Blood Coagulation and Thrombosis Mechanisms, Blood properties and coagulation and Venous Thromboembolism Diagnosis and Management.
- World rank
- #5,245,313 of 7,710,434 ranked researchers
- Rank in Japan
- #171,377 of 383,136
- Works
- 63
- Citations
- 981
- Citations per work
- 15.6
What does Chika Uotani research?
Chika Uotani's work is mostly in Medicine (59%), Biochemistry, Genetics and Molecular Biology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3759.0%
- Medicine3759.0%
- Everything else2032.1%
- Life Sciences68.9%
- 1Hematology24% of their works
- 2Pulmonary and Respiratory Medicine16% of their works
- 3Cancer Research9% of their works
- 4Oncology7% of their works
- 5Internal Medicine7% of their works
- 6Surgery4% of their works
Research topics
- Blood Coagulation and Thrombosis Mechanisms
- Blood properties and coagulation
- Venous Thromboembolism Diagnosis and Management
- Protease and Inhibitor Mechanisms
- Hemophilia Treatment and Research
- Platelet Disorders and Treatments
- Colorectal Cancer Screening and Detection
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Which keywords describe Chika Uotani's research?
The keywords of their largest research topics: Hemostasis, Antithrombotic Therapy, Inflammation, Protease-Activated Receptors, Thrombin, Fibrinogen, Transglutaminases and Prophylaxis.
- JAK2 Mutation
- Colorectal Cancer
- Platelets
- Factor VIII
- Matrix Metalloproteinases
- Pulmonary Embolism
- Prophylaxis
- Fibrinogen
- Protease-Activated Receptors
- Antithrombotic Therapy
- Hemostasis
- Inflammation
- Thrombin
- Transglutaminases
- Risk Factors
- Venous Thromboembolism
- Tissue Inhibitors of Metalloproteinases
- Hemophilia
- Thrombosis
- Screening
- Myelofibrosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 21 words, with their numbers
- Hemostasis503 topics
- Antithrombotic Therapy372 topics
- Inflammation312 topics
- Protease-Activated Receptors261 topic
- Thrombin261 topic
- Fibrinogen191 topic
- Transglutaminases191 topic
- Prophylaxis172 topics
- Risk Factors152 topics
- Pulmonary Embolism111 topic
- Venous Thromboembolism111 topic
- Matrix Metalloproteinases101 topic
- Tissue Inhibitors of Metalloproteinases101 topic
- Factor VIII61 topic
- Hemophilia61 topic
- Platelets51 topic
- Thrombosis51 topic
- Colorectal Cancer41 topic
- Screening41 topic
- JAK2 Mutation31 topic
- Myelofibrosis31 topic
Where does Chika Uotani work?
Chika Uotani's main affiliation in the publication record is Kanazawa University, Japan.
How many publications and citations does Chika Uotani have?
OpenAlex counts 63 works and 981 citations for Chika Uotani, an h-index of 19, ranking #5,245,313 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Chika Uotani. Posts are plain text and can be reported.